NASDAQ:GENE
Delisted

Genetic Technologies Stock Predictions

etoro logo Buy GENE
*Your capital is at risk
$0.765
+0 (+0%)
At Close: Jan 15, 2025
Currently predicting for Mon, 8 Jun 2026

GENE Prediction Chart

GENE Predictions History

Latest community submissions for GENE.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 23, 2019 $0.441 -47.75% $0.84 V 52.30% 0
Jan 22, 2018 $1.40 -16.17% $1.67 X 83.80% 0
May 4, 2017 $1.52 +36.69% $1.11 X 63.30% 0
JS JS Pro
May 3, 2017 $1.16 +0.00% $1.16 X 100.00% 10
May 3, 2017 $1.13 -2.59% $1.16 X 97.40% 0
May 3, 2017 $1.19 +2.59% $1.16 X 97.40% 0
May 3, 2017 $2.55 +119.83% Unrealistic Excluded from avg $1.16 X 0.00% 0
john75 john75 @john75.5525
May 1, 2017 $1.19 -2.46% $1.22 X 97.50% 0
May 1, 2017 $1.23 +0.82% $1.22 X 99.20% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GENE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GENETIC TECHNOLOGIES LTD
Genetic Technologies
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecol...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE